Search - tctmd.com

Displaying 1 - 20 of 110

Sort: Relevancy | Date

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Conference News CX Symposium 2025

Plant-Derived Compound Shows Early Promise for Small AAAs

L.A. McKeown

April 25, 2025

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Michael O'Riordan

December 18, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

Advertisement

January 2026 Dispatch for the CV Team

September 2025 Dispatch for the CV Team

July 2025 Dispatch for the CV Team

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

May 2025 Dispatch for the CV Team

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Plant-Derived Compound Shows Early Promise for Small AAAs

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

With ANOCA, Better to Test Coronary Function in Multiple Vessels

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

May 2024 Dispatch for the CV Team

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Top Coronary Artery Disease News of 2023

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

December 2023 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content